| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.03 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.03 |